Extra Virgin Olive Oil Modulates Vasodilator Enzyme Level by Repairing Angiogenesis Function in Rat Model of Preeclampsia
-
Yulia Silvani
,
Agnestia Naning Dian Lovita
,
Afniari Maharani
,
I Wayan Arsana Wiyasa
,
Hidayat Sujuti
,
Retty Ratnawati
,
Tri Yudani Mardining Raras
Abstract
Objective: This study aimed to determine the effect of Extra Virgin Olive Oil (EVOO) on vasodilator enzyme by repairing angiogenic function in rat model of preeclampsia.
Materials and methods: This research consisted of five groups; negative control (normal pregnant rats) group, positive control (preeclampsia rat model) group, preeclampsia rat model groups given EVOO in 3 different doses (0.5 ml/day, 1 ml/day, and 2 ml/day, respectively). Blood pressure measurements were carried out on day 12, 15, and 19 of pregnancy. After the rats were sacrificed, the placentas were collected to determine endothelial Nitric Oxide Synthase (eNOS) level of maternal plasma to determine soluble Fms-like Tyrosine Kinase 1 (sFlt-1) and Vascular Endothelial Growth Factor (VEGF) level.
Results: There were significant higher sFlt-1 level (p < 0.001), lower VEGF level (p = 0.009), and lower eNOS level (p = 0.034) between negative and positive control groups. After EVOO administration, sFlt-1 level was lower in dose 1 and 2 groups but higher in dose 3 group in accordance with VEGF and eNOS levels that were increasing both in dose 1 and dose 2 groups but decreasing in dose 3. There were significant differences between positive control and dose 1 (p = 0.015) and dose 2 (p = 0.001) in sFlt-1 level. None of all dose groups were statistically different with positive control group in VEGF level (dose 1 p = 0.601; dose 2 p = 0.297; dose 3 p = 0.805). eNOS levels of all dose groups were statistically different from that of the positive control group (dose 1 p = 0.014; dose 2 p = 0.001; dose 3 p = 0.024).
Conclusion: Administration of EVOO modulates eNOS as vasodilator enzyme by repairing the angiogenic function indicated by decreased sFlt-1 level and increased VEGF in rat model of preeclampsia.
2. Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiology.Cardiovasc J Afr 2016; 27: 71–8.
3. Sanjay G, Girija W. Preeclampsia – Eclampsia.
J Obstet Gynaecol India 2014; 64: 4-13.
4. Yuan HT, Haig D, Karumanchi SA. Angiogenic Factors In The Pathogenesis Of Preeclampsia. Curr Top Dev Biol 2005; 71: 297-321.
5. Myatt L, Webster RP. Vascular Biology of
Preeclampsia. J Thromb Haemost 2009; 7: 375–84.
6. Stepan H, Faber R, Dornhöfer N, Huppertz B, Robitzki A, Walther T. Minireview New Insights Into The Biology Of Preeclampsia. Biol Reprod 2006; 74: 772–6.
7. Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Mapping The Theories Of Preeclampsia And The Role Of Angiogenic Factors. Obstet Gynecol 2007; 109: 168–80.
8. Fearnley GW, Smith GA, Harrison MA, Wheatcroft SB. Vascular Endothelial Growth Factor-A Regulation Of Blood Vessel Sprouting In Health And Disease. Biochem 2013; 1: 1–9.
9. Choi YK, Kim C, Lee H, Jeoung D, Ha K, Kwon Y, et al. Carbon Monoxide Promotes VEGF Expression By Increasing HIF-1 A Protein Level Via Two Distinct Mechanisms , Translational Activation And Stabilization Of HIF-1α Protein. J Biol Chem 2010; 285: 32116–25.
10. Schwager SJ, Mutschler MA, Federer WT, Scully BT. The Effect Of Linkage On Sample Size Determination For Multiple Trait Selection. Theor. Appl. Genet 1993; 86: 964–74.
11. Irianti E, Ilyas S, Rosidah, Hutahaean S. Hsp70 Expression Profile In Preeclampsia Model Of Pregnant Rat ( Rattus Norvegicus ) After Giving The EVOO Hsp70 Expression Profile In Preeclampsia Model Of Pregnant Rat ( Rattus Norvegicus ) After Giving The EVOO. IOP Conf. Ser.: Mater. Sci. Eng 2017; 180: 1–6.
12. Shu WEN, Li H, Gong Hao, Zhang Mei, Niu X, Ma Y, et al. Evaluation of blood vessel injury , Oxidative stress and circulating inflammatory factors In An L ‑ NAME ‑ Induced Preeclampsia ‑ Like Rat Model. Exp Ther Med 2018; 16: 585–94.
13. Amaral TAS, Ognibene DT, Carvalho LCRM, Paula A, Rocha M, Costa CA, Moura RS, et al. Differential responses of mesenteric arterial bed to vasoactive substances In L-NAME-Induced Preeclampsia : Role of oxidative stress and endothelial dysfunction. Clin Exp Hypertens 2017; 40: 126–35.
14. Zhu H, Zhu W, Hu R, Wang H, Ma D, Li X. The Effect Of Pre-Eclampsia-Like Syndrome Induced By L-NAME On Learning and memory and hippocampal glucocorticoid receptor expression : A rat model. Hypertens Pregnancy 2017; 36: 36–43.
15. Liu Q, Yang J. Expression and significance of miR155 and vascular endothelial growth Factor In Placenta of rats with preeclampsia. Int J Clin Exp Med 2015; 8: 15731–7.
16. Oludare GO, Jinadu HD, Aro OO. L-arginine attenuates blood pressure and reverses the Suppression of angiogenic risk factors in a rat model of preeclampsia. Pathophysiology 2018; 25: 389-95.
17. Laskowska M, Laskowska K, Oleszczuk J. The relation of maternal serum eNOS, NOSTRIN and ADMA Levels with aetiopathogenesis of preeclampsia and/or Intrauterine fetal growth Restriction. J Matern Fetal Neonatal Med 2015; 28: 26–32.
18. Bermudez B, Lopez S, Ortega A, Varela L M. Pacheco YM, Abia R, et al. Oleic Acid In Olive Oil: From a metabolic framework toward a clinical perspective. Curr Pharm Des 2011; 17: 831–43.
19. Escrich E, Moral R, Solanas M. Olive Oil, an essential component of the Mediterranean Diet, and Breast cancer. Public Health Nutr 2011; 14: 2323–32.
20. Kweider N, Fragoulis A, Rosen C, Pecks U, Rath W, Pufe T, et al. Interplay between vascular Endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2) : implications for preeclampsia. J Biol Chem 2011; 286: 42863–72.
21. Chen X, Liu J, He B, Li Y, Liu S, Wu B, et al. Vascular endothelial growth factor (VEGF) Regulation by hypoxia inducible factor-1 alpha (HIF1A) starts and peaks during endometrial Breakdown, not repair, In a mouse menstrual-Like model. Hum Reprod 2015; 30: 2160–70.
22. Carrasco-Pancorbo A, Cerretani L, Bendini A, Segura-Carretero A, Del Carlo M, Gallina-Toschi T, et al. Evaluation of the antioxidant capacity of individual phenolic compounds in virgin olive oil. J Agric Food Chem 2005; 53: 8918–25.
23. Acin S, Navarro MA, Arbones-Mainar JM, Guillen N, Sarria AJ, Carnicer R, et al. Hydroxytyrosol Administration Enhances Atherosclerotic Lesion Development In Apo E Deficient Mice. J Biochem 2006; 140: 383–91.
24. Parameswaran N, Patial S. Tumor Necrosis factor-A signaling in macrophages. Crit Rev Eukaryot Gene Expr 2010; 20: 87–103.
25. Parrish MR, Murphy SR, Rutland S, Wallace K, Wenzel K, Wallukat G, et al. The Effect of Immune Factors, Tumor Necrosis Factor-alpha, and Agonistic Autoantibodies to the Angiotensin II Type I Receptor on Soluble fms-Like Tyrosine-1 and Soluble Endoglin Production in Response to Hypertension During Pregnancy. Am J Hypertens 2010; 23: 911–6.
26. Murphy SR, LaMarca BB, Parrish M, Cockrell K, Granger JP. Control Of Soluble Fms-Like Tyrosine-1 (SFlt-1) Production response to placental Ischemia/hypoxia: role of tumor necrosis Factor-α. Am J Physiol Regul Integr Comp Physiol 2013; 304: R130-5.
27. Helmo FR, Lopes AMM, Carneiro ACDM, Campos CG, Silvia PB, Dos Reis Monteiro MLG, et al. Angiogenic and antiangiogenic factors In preeclampsia. Pathol Res Pract 2018; 214: 7–14.
28. Maurya DK, Devasagayam TP. Antioxidant And Prooxidant nature of hydroxycinnamic acid Derivatives ferulic and caffeic acids. Food Chem Toxicol 2010; 48: 3369–73.
29. Perron NR, García CR, Pinzón JR, Chaur MN, Brumaghim JL. Antioxidant and prooxidant effects Of polyphenol compounds on copper-mediated DNA damage. J Inorg Biochem 2011; 105: 745–53.
| Files | ||
| Issue | Vol 14, No 1 (March 2020) | |
| Section | Original Articles | |
| DOI | https://doi.org/10.18502/jfrh.v14i1.3786 | |
| Keywords | ||
| Preeclampsia Extra Virgin Olive Oil Vascular Endothelial Growth Factor Endothelial Nitric Oxide Synthase Angiogenic Factor | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
